The spread between trailing and forward P/E implies that analysts expect net income to expand sharply from the near-breakeven levels seen in early 2025, which is consistent with the operating margin recovery visible in the ratio data. EV/EBITDA of 12.21 compared with a forward multiple of 8.38 points the same way, and the P/FCF of 30.60 is more demanding than the EBITDA multiple, suggesting that capital intensity absorbs a meaningful share of operating cash generation. Relative to peers, SHC's forward multiples appear reasonable against MEDP and CRL, though the valuation depends heavily on forecasts that have not yet been demonstrated on a sustained basis.

The improvement in interest coverage is largely driven by operating margin expansion rather than any reduction in the approximately $2.3B debt stack, which means the coverage gains are sensitive to margin durability. A debt-to-EBITDA ratio of around 15 in the latest quarter is still elevated on an annualized basis and leaves limited room to absorb a litigation settlement or a compliance-driven capital outlay without additional borrowing. Investors should monitor whether free cash flow allocation continues to prioritize deleveraging, since refinancing risk becomes more relevant if EBITDA growth stalls.

The gap between high gross margins and low ROIC indicates that the large asset base, including roughly $1.2B of net PP&E and $1.1B of goodwill, is absorbing much of the economic value generated by operations. ROE is flattered relative to ROIC by the leverage embedded in the capital structure, so the equity return should not be read as evidence of efficient capital deployment. The trend is directionally positive, but whether returns compound toward a more attractive level depends on sustained margin expansion and disciplined capital spending.

The quick ratio sits close to the current ratio, which is expected given the limited inventory dependence of a service-based sterilization model, so the liquidity read is not distorted by inventory build. Under a severe stress scenario, the relevant question is whether the $412.4M cash balance would be sufficient to meet litigation settlements alongside scheduled debt service, and the reported figures alone do not establish that answer. The position appears adequate on a near-term basis but warrants further investigation of the timing and size of potential legal outflows.